3594 related articles for article (PubMed ID: 14696397)
21. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
22. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
24. [The transjugular intrahepatic portosystemic stent-shunt (TIPS) in the management of portal hypertension. A preliminary report].
Aguilar Ramírez JR; Alcantara Peraza RA; Hernández Pérez RE; Gómez Maganda y Silva T; Heredia Jarero NM; Torres Valadez F; Gómez del Campo López A
Rev Gastroenterol Mex; 1994; 59(3):218-22. PubMed ID: 7716362
[TBL] [Abstract][Full Text] [Related]
25. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
26. [Surgical approach to posthepatitic cirrhotic patient today].
Meriggi F; Forni E
G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
[TBL] [Abstract][Full Text] [Related]
27. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
Brown RS; Lake JR
Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
29. Surgical shunts and TIPS for variceal decompression in the 1990s.
Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
[TBL] [Abstract][Full Text] [Related]
30. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic portosystemic shunt in treatment of complications of portal hypertension.
Wróblewski T; Rowiński O; Pawlak J; Małkowski P; Ziarkiewicz-Wróblewska B; Michałowicz B; Zurakowski J; Krawczyk M
Med Sci Monit; 2001 May; 7 Suppl 1():305-10. PubMed ID: 12211743
[TBL] [Abstract][Full Text] [Related]
32. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
[TBL] [Abstract][Full Text] [Related]
34. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
Rössle M; Haag K; Ochs A; Sellinger M; Nöldge G; Perarnau JM; Berger E; Blum U; Gabelmann A; Hauenstein K
N Engl J Med; 1994 Jan; 330(3):165-71. PubMed ID: 8264738
[TBL] [Abstract][Full Text] [Related]
35. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.
Spahr L; Fenyves D; N'Guyen VV; Roy L; Legault L; Dufresne MP; Pomier-Layrargues G
Am J Gastroenterol; 1995 Jul; 90(7):1169-71. PubMed ID: 7611221
[TBL] [Abstract][Full Text] [Related]
36. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
Choi DX; Jain AB; Orloff MS
J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
[TBL] [Abstract][Full Text] [Related]
38. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
Gerbes AL; Gülberg V; Waggershauser T; Holl J; Reiser M
Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
[TBL] [Abstract][Full Text] [Related]
39. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
